# Combined Advanced Targeted Therapy for Inflammatory Bowel Disease

> **NCT07660289** · — · COMPLETED · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 117 (actual)

## Conditions studied

- IBD (Inflammatory Bowel Disease)
- Combined Advanced Targeted Therapy
- Combination Therapy

## Interventions

- **DRUG:** Combination therapy

## Key facts

- **NCT ID:** NCT07660289
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-20
- **Primary completion:** 2026-05-10
- **Final completion:** 2026-06-10
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660289, "Combined Advanced Targeted Therapy for Inflammatory Bowel Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*